ASPIRE BIOPHARMA HLDGS INC

Historical 13F Holders

Symbol
ASBP
CUSIP
738920107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 738920107 since 12/18/2024, newest first.

Filer % of Class Filed
Ardsley Advisory Partners LP 13G/A Amendment 1
0% 5/13/2026
Event 12/31/2025
Ardsley Advisory Partners LP 13G
7.8% 2/12/2026
Event 12/31/2025
Lance Friedman 13G/A Amendment 9 4.5% 5/19/2025
Event 5/6/2025
Harraden Circle Investments, LLC 13G/A Amendment 1
0.3% 5/15/2025
Event 3/31/2025
Lance Friedman 13G/A Amendment 8 7.9% 5/7/2025
Event 4/29/2025
Lance Friedman 13G/A Amendment 7 8.3% 4/23/2025
Event 4/21/2025
Lance Friedman 13G/A Amendment 6 8.3% 4/17/2025
Event 4/11/2025
Lance Friedman 13G/A Amendment 5 8.6% 4/11/2025
Event 4/4/2025
Lance Friedman 13G/A Amendment 4 9.0% 4/4/2025
Event 3/26/2025
Lance Friedman 13G/A Amendment 3 9.1% 3/28/2025
Event 3/19/2025
Lance Friedman 13G/A Amendment 2 9.5% 3/20/2025
Event 3/3/2025
Lance Friedman 13G/A Amendment 1 9.8% 3/12/2025
Event 3/3/2025
Lance Friedman 13G 10.0%
Checked 5% or less
2/26/2025
Event 2/17/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 33.0 $276.00
2026 Q2 1 33.0 $176.00
2026 Q1 2 25.3 k $8.45 k
2025 Q4 30 6.82 M $900 k
2025 Q3 25 3.12 M $646 k
2025 Q2 17 2.04 M $545 k
2025 Q1 16 1.44 M $876 k